NIH R01 · 2025
PROJECT SUMMARY We propose a multi-center hybrid type I effectiveness-implementation trial to assess patient-facing evidence- based guidelines through a mHealth application plus (+) booklets in adults with sickle cell disease (SCD). Clinicians’ care of SCD is informed by evidence-based guidelines, which target the prevention of morbidity and mortality. The National Heart, Lung, and Blood Institute (NHLBI) and the American Society of Hematology (ASH) published guidelines for evidence-based management of SCD for healthcare providers. However, patient, provider, or system barriers prohibit adequate reach within and across all three domains, leading to poor guideline adherence. Our prior work…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.